Home » Newsletters » BioWorld

BioWorld

Feb. 7, 1995

View Archived Issues

CIBA VISION, QUADRA LOGIC FINALIZE DEVELOPMENT DEAL

TRANSGENIC MOUSE CREATED AS SURROGATE FOR MODELING LOU GEHRIG'S DISEASE

IBRD ACQUIRES UK-BASED CRO, ROSTRUM

BIOCRYST REPORTS POSITIVE DATA FROM PHASE II TRIALS

SCIENCE, TECHNOLOGY ARE STATUS QUO IN CLINTON'S 1996 BUDGET

LIGAND SIGNS POTENTIAL $21.5M DEAL WITH SMITHKLINE FOR BLOOD CELL

DRUG LICENSING AGENCY OPENS FOR BUSINESS EUROPE LAUNCHES NEW LICENSING

PROTEIN ENGINEERING, STRUCTURAL BIO CONCLAVE HONORS NOBELISTS

CELTRIX DROPS BETAKINE OPHTHALMIC PROGRAM; STOCK FALLS 40 PERCENT

THINK TANK CRAFTS A REPLACEMENT FOR THE FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...